Efficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-naïve Fabry disease patients.
about
Efficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-naïve Fabry disease patients.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Efficacy and safety of enzyme- ...... -naïve Fabry disease patients.
@ast
Efficacy and safety of enzyme- ...... -naïve Fabry disease patients.
@en
type
label
Efficacy and safety of enzyme- ...... -naïve Fabry disease patients.
@ast
Efficacy and safety of enzyme- ...... -naïve Fabry disease patients.
@en
prefLabel
Efficacy and safety of enzyme- ...... -naïve Fabry disease patients.
@ast
Efficacy and safety of enzyme- ...... -naïve Fabry disease patients.
@en
P2860
P1476
Efficacy and safety of enzyme- ...... -naïve Fabry disease patients.
@en
P2093
Hiroshi Yamamoto
Kazuya Tsuboi
P2860
P2888
P356
10.1186/S40360-017-0152-7
P577
2017-06-07T00:00:00Z